The Tenex Health TX® EQ Advantage

Tendinopathy and desmitis are debilitating pathologies that can severely affect the utility and performance of the horse.  A 2014 study by Plevin and McLellan found that almost 10% of 2-year-old Thoroughbred horses were affected by suspensory branch desmitis. The Tenex Health Tx ® Microtip technology was developed at the Mayo Clinic and has been used on over 100,000 human patients with outstanding results.

Tenex Health TX ® EQ Microtip technology is the only system available in the US that utilizes ultrasonic energy to cut, debride and remove damaged tendon and ligament tissue.  By excising non-structural debris, neovascularization and regenerative cells will populate the newly cleared space.  Other treatment modalities, including ECSWT, fasciotomy/neurectomy and prolonged rest are completely ineffective at removing scar and debris within an injured tendon or ligament.

The TX EQ Microtip does not harm healthy tissue and is extremely well-tolerated by the horse.  The minimally invasive procedure generally takes less than 10 minutes and may be performed in the standing or recumbent patient, and depending on the severity of the original injury, return to use is generally within a matter of weeks.  Indications for the Tenex TX EQ Microtip include diffuse tendinitis, core lesions of the SDF, DDF and ICL, suspensory ligament and suspensory branch desmitis, removal of dystrophic calcification, osteochondroma, and many more.

Discover the Tenex Health TX ® EQ Advantage. Successful treatment is a Microtip away!

  • For ordering information, sales and training please fill out the form below or give us a call at 307-578-7877.

  • This field is for validation purposes and should be left unchanged.